<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="26060" whole_study_id="26060" phs="001484" v="1" p="1" createDate="2017-07-13T15:17:29-05:00" completedByGPADate="2017-07-27T12:38:11-05:00" modDate="2022-03-03T10:50:25-05:00" maxParentChildStudyModDate="2022-03-03T10:50:25-05:00" handle="Atazanavir_Bilirubin" num_participants="321"><StudyInfo accession="phs001484.v1.p1" parentAccession="phs001484.v1.p1"><BioProject id="PRJNA417885" entrez_id="417885" type="bp_data_submission"/><BioProject id="PRJNA417884" entrez_id="417884" type="bp_admin_access"/><StudyNameEntrez>Atazanavir Bilirubin-related Side Effects</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType></StudyTypes><Funding>R01 AI077505</Funding></StudyInfo><Authority><ICs><IC id="5" name="NIAID" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="HAASDW" aid="2" auth="eRA" login="HAASDW" fname="David" mname="" lname="Haas" email="david.haas@vumc.org"><Role allow_direct_access="true">PI</Role><Organization>VANDERBILT UNIVERSITY MEDICAL CENTERVANDERBILT UNIVERSITY</Organization></Person><Person nedid="0011592222" aid="1" auth="cit" login="hazhang" fname="Hao" mname="" lname="Zhang" email="hazhang@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013043239" aid="1" auth="cit" login="pretels" fname="Renate" mname="S" lname="Pretel" email="pretels@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2003273233" aid="1" auth="cit" login="vanpanhuiswg" fname="Willem" mname="Gijsbert" lname="Van Panhuis" email="wilbert.vanpanhuis@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Funding for the study of &#8220;Pharmacogenomics of HIV Therapy - Atazanavir Bilirubin-related Side Effects&#8221; was provided from the NIAID (Grant/Contract # R01 AI077505). Additional Support included P30 AI110527.
The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/projects/gap/XXXXX through dbGaP study accession numbers xxxxx.  Data from the &#8220;Pharmacogenomics of HIV Therapy - Atazanavir Bilirubin-related Side Effects&#8221; Project were provided by David W. Haas, MD on behalf of his collaborators at Vanderbilt University Medical Center.
David W. Haas, MD and his collaborators request that publications resulting from these data cite their original publication (to follow, after submission)
</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="2657" CGType="cg_class_DS" title="Disease-Specific (Human Immunodeficiency Virus, IRB)" name="DS-HIV-IRB" dac_uid="65" dac_name="NIAID " irb-approval-required="Yes"><Use-Restriction>Use of the data must be related to Human Immunodeficiency Virus.
Requestor must provide documentation of local IRB approval.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>